AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS. Mediterr J Hematol Infect Dis [Internet]. 2014 Jun. 29 [cited 2026 Jun. 2];6(1):e2014047. Available from: https://www.mjhid.org/mjhid/article/view/2014.047